 | Thursday, January 24, 2019 Why You Won't See a Pure-Play Hemp IPO in Our Portfolio Anytime Soon By Greg Miller
With the introduction of the 2018 Farm Bill, U.S hemp cultivation is finally legal.
That led to a flood of questions from our readers. Folks wanted to know if there were any "pure-play hemp" IPOs on the horizon.
That's fair.
I've been upfront that my goal with the National Institute for Cannabis Investors is to provide you all with the information, access, and guidance needed to make a fortune in cannabis.
But I have to be frank: I don't see a pure-play hemp pick in our portfolio anytime soon.
Right now, hemp is a big buzzword on Wall Street, just like blockchain was in 2017. To cash in on the craze, Long Island Ice Tea entered the crypto market and changed its name to Long Blockchain Corp.
The stock price exploded 341% to $9.49 per share, thanks to the name change.
Do you know how much a share of Long Blockchain is worth today?
Less than 20 cents.
I'm not going to send you down a similar path, chasing returns from buzzwords on Wall Street.
Instead, I'm going to show you how to unlock the most significant gains the cannabis industry has to offer...
  Pot Stock Alert: Now's the Time to Strike on These High-Flying Cannabis Trades
Yesterday, our team of analysts handed down their trade instructions for our next runaway pot stock recommendations. And I'm inviting you to join them now before the gains really start rolling in. The NICI team believes that these stocks could rapidly become our next double or even triple-digit winners practically overnight. Think about that for a second. That would be ten times your initial investment on each trade. You just have to click here to learn more about this rare opportunity.
Our "Vault" of cannabis stocks could be your best shot at becoming a "Marijuana Millionaire." Our one-of-a-kind stock database, what we at the Institute like to call "The Vault," is easily the most comprehensive database of cannabis companies on the planet. It includes every publicly traded cannabis company, a number of companies planning on going public soon, and a lot of extremely promising new startups. All of these companies have undergone our extensive vetting process. They've all been rated on our simple 1-5 scale. And if you click the link below, you can access this vault for yourself to help you find more winners... giving you the potential to make more money, even faster.
| 
You are receiving this e-mail at its028@gmail.com, as a part of your subscription.
Remove your email from this list: Unsubscribe
© 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201.
Privacy Policy | Terms & Conditions
| |
没有评论:
发表评论